Computational Biology Market By Application (Cellular And Biological Simulation, Disease Modelling And Drug Discovery, Preclinical Drug Development, Clinical Trials, Human Body Simulation), By Component (Hardware, Software & Services, Databases), By Service Type (In-house, Contract Services), By End User (Industrial Applications, Research And Academia) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026
Industry Outlook
Computational biology is an interdisciplinary science that is being persistently advancing through the previous decades by using the power of mathematics and computation. The primary aim of computational biology is to employ large-scale computational methods to the fields of cellular, structural and molecular biology for answering emerging biological questions which were earlier not possible to be tackled with traditional approaches. The foundation of computational biology lies in computer science, statistics, chemistry, biochemistry, mathematics, genomics, genetics, molecular biology, neuroscience, animation, anatomy, visualization etc. thousands have researchers have come up with a wide range of computational methods to study areas such as structure prediction, cell signaling, metabolic networks, protein design and gene regulation.
Therefore computational biology involves use of biological data for construction of relations and algorithms in biological systems for analysis of biological similarities and differences. Computational biology is majorly applied in cancer research, genomics and proteomics, pharmacology, neuroscience, genomics and biomodeling. The field of computational biomodeling comprises computer-aided biological models that aim to design algorithms for accurate visualization of simulations for examining biological complexities. Similarly, computational neuroscience applies computational biology for understanding neurological pathways and brain models. Computational biology is also used in pharmacology in the form of visual simulations for understanding drug interactions. Increase in bioinformatics research is the prime factor driving the growth of computational biology market. Its widening application in genomics, drug development programs, drug designing and other lucrative areas is anticipated to reduce the lead time to drug commercialization therefore reduce the average cost as against conventional methods. Such grounds are therefore anticipated to drive stable growth of computational biology market during the forecast period from 2018 to 2026.
"Disease Modeling and Drug Discovery Leading the Applications Worldwide"
Based on the application areas, the global computational biology market is segmented into cellular and biological simulation, disease modelling and drug discovery, preclinical drug development, clinical trials and human body simulation. As the lead time and average costs for commercializing any drug to the market has been continuously increasing to reach the billion mark in the last decades, there is a dire need for devising new methods to speed up the process while containing the costs. Along with this, high scale of failure of clinical trials in early phases of development has also led to the dominance of disease modeling and drug discovery application in 2017. The lead of this segment is anticipated to continue through the forecast period.
"Software and Databases to Determine the Market Size in the Future"
Hardware, software and services, and databases are the tools that together make practical computational biology. Computational biology is mainly formed of algorithms and logics created through biological data computation and databases comprising genomic data; hardware processor units for computation also form an integral part of this field. As the major applications of computational biology proliferate in other life-science industries, the demand for these tools will correspondingly proliferate. Software, services and databases are the key segments that occupy the largest revenue share in the global computational biology market. constant need for periodic updating software and databases and significantly large costs of these items contribute to the dominance of these segments.
"Current Restrictions on In-house Affordability to Facilitate the Demand for Contract Services"
Based on service type, computational biology market is segmented into in-house and contract services. Outsourcing to service institutions is the key trend observed in this market. Computational biology requires high process and sophisticated computing technologies, which cannot be a core competency of every pharmaceutical or life-sciences company. Furthermore, affordability to these technologies may also be an issue, barring major pharma giants. Therefore, for several pharmaceutical and life-science players, outsourcing of computational biology activities remain the only plausible resort.
"United States Leads the Global Computational Biology Market due to Greater Awareness and Supportive Business Environment"
The major regions that cumulate to the global computational biology market are North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among these, North America is the clear leader in the global market in terms of revenue, higher quantities of investments in life-science research and development of drugs and diagnostics, and phenomenal technological advancements in biotechnology are the key contributors to the dominance of North America market. Europe closely follows the lead of North America. Rapid adoption of novel biotechnologies, greater awareness and availability of required skill sets and favorable affordability are the characteristic features of Europe market. Asia Pacific is the fastest progression regional market for computational biology. Proliferating contract research services industry in the region, facilitated by favorable government policies, and growing pool of skilled workforce has urged several companies to outsource their computational requirements to service providers in Asia Pacific.
Historical & Forecast Period
This research report presents the analysis of each considered segment for the period from 2016 to 2026, having 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.
The report also presents insights on the competitive landscape prevalent in the global computational biology market along with profiling of key companies operating in the industry. Such major market players profiled in this report include Rhenovia Pharma SAS, Chemical Computing Group Inc., Compugen, Ltd., Accelrys, Insilico Biotechnology AG, Nimbus Discovery LLC, Entelos, Simulation Plus, Inc., Genedata AG, Leadscope, Inc., and Certara.
Key questions answered in this report
- What is the market size of the global computational biology market in 2017 and how will the market fare through 2026?
- What is the status of disease modelling and drug discovery segment and what reasons lead to the dominance of this segment?
- How software and services, and databases segment are the largest segments in the global market?
- How contract research organizations are challenging the position of in-house services?
- Will Asia Pacific majorly challenge the dominance of North America market?
- At what CAGR will emerging markets of Asia Pacific, Latin America and Middle East & Africa markets growth during the forecast period from 2016 to 2026?
- Which strategies are being employed by the market players for sustenance and augmenting market share?
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global CB Market Portraiture
2.2. Global CB Market, by Application, 2017 (US$ Mn)
2.3. Global CB Market, by Component, 2017 (US$ Mn)
2.4. Global CB Market, by Service Type, 2017 (US$ Mn)
2.5. Global CB Market, by End User, 2017 (US$ Mn)
2.6. Global CB Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Computational Biology (CB) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CB Market, by Key Players, 2017
Chapter 4. Global Computational Biology (CB) Market, by Application, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Cellular and Biological Simulation
4.2.1. Computational Genomics
4.2.2. Computational Proteomics
4.2.3. Pharmacogenomics
4.2.4. Transcriptomics/Metabolomics
4.3. Disease Modelling and Drug Discovery
4.3.1. Target Identification
4.3.2. Target Validation
4.3.3. Lead Discovery
4.3.4. Lead Optimization
4.4. Preclinical Drug Development
4.4.1. Pharmacokinetics
4.4.2. Pharmacodynamics
4.5. Clinical Trials
4.6. Human Body Simulation
Chapter 5. Global Computational Biology (CB) Market, by Component, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Hardware
5.3. Software & Services
5.4. Databases
Chapter 6. Global Computational Biology (CB) Market, by Service Type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. In-house
6.3. Contract Services
Chapter 7. Global Computational Biology (CB) Market, by End User, 2016-2026 (US$ Mn)
7.1. Overview
7.2. Industrial Applications
7.3. Research and Academia
Chapter 8. Global Computational Biology (CB) Market, by Geography, 2016 – 2026 (US$ Mn)
8.1. Overview
8.1.1. North America CB Market, 2016-2026 (US$ Mn)
8.1.2. North America CB Market, by Application, 2016 - 2026 (US$ Mn)
8.1.3. North America CB Market, by Component, 2016 - 2026 (US$ Mn)
8.1.4. North America CB Market, by Service Type, 2016 - 2026 (US$ Mn)
8.1.5. North America CB Market, by End User, 2016 - 2026 (US$ Mn)
8.1.6. North America CB Market, by Country, 2016 – 2026 (US$ Mn)
8.1.6.1. U.S.
8.1.6.2. Canada
8.2. Europe CB Market, 2016 – 2026 (US$ Mn)
8.2.1. Europe CB Market, by Application, 2016 - 2026 (US$ Mn)
8.2.2. Europe CB Market, by Component, 2016 - 2026 (US$ Mn)
8.2.3. Europe CB Market, by Service Type, 2016 - 2026 (US$ Mn)
8.2.4. Europe CB Market, by End User, 2016 - 2026 (US$ Mn)
8.2.5. Europe CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.2.5.1. U.K.
8.2.5.2. Germany
8.2.5.3. Rest of Europe
8.3. Asia Pacific CB Market, 2016 – 2026 (US$ Mn)
8.3.1. Asia Pacific CB Market, by Application, 2016 - 2026 (US$ Mn)
8.3.2. Asia Pacific CB Market, by Component, 2016 - 2026 (US$ Mn)
8.3.3. Asia Pacific CB Market, by Service Type, 2016 - 2026 (US$ Mn)
8.3.4. Asia Pacific CB Market, by End User, 2016 - 2026 (US$ Mn)
8.3.5. Asia Pacific CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.3.5.1. China
8.3.5.2. Japan
8.3.5.3. Rest of Asia Pacific
8.4. Latin America CB Market, 2016 – 2026 (US$ Mn)
8.4.1. Latin America CB Market, by Application, 2016 - 2026 (US$ Mn)
8.4.2. Latin America CB Market, by Component, 2016 - 2026 (US$ Mn)
8.4.3. Latin America CB Market, by Service Type, 2016 - 2026 (US$ Mn)
8.4.4. Latin America CB Market, by End User, 2016 - 2026 (US$ Mn)
8.4.5. Latin America CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.4.5.1. Brazil
8.4.5.2. Mexico
8.4.5.3. Rest of Latin America
8.5. Middle East & Africa CB Market, 2016 – 2026 (US$ Mn)
8.5.1. Middle East & Africa CB Market, by Application, 2016 - 2026 (US$ Mn)
8.5.2. Middle East & Africa CB Market, by Component, 2016 - 2026 (US$ Mn)
8.5.3. Middle East & Africa CB Market, by Service Type, 2016 - 2026 (US$ Mn)
8.5.4. Middle East & Africa CB Market, by End User, 2016 - 2026 (US$ Mn)
8.5.5. Middle East & Africa CB Market, by Region, 2016 – 2026 (US$ Mn)
8.5.5.1. GCC
8.5.5.2. Rest of Middle East & Africa
Chapter 9. Company Profiles
9.1. Rhenovia Pharma SAS
9.1.1. Business Description
9.1.2. Financial Information (Subject to Data Availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. Chemical Computing Group Inc.
9.3. Compugen, Ltd
9.4. Accelrys
9.5. Insilico Biotechnology AG
9.6. Nimbus Discovery LLC
9.7. Entelos
9.8. Simulation Plus, Inc.
9.9. Genedata AG
9.10. Leadscope, Inc
9.11. Certara
* CB - Computational Biology
TABLE 1 Global Computational Biology (CB) Market Portraiture
TABLE 2 Global CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 3 Global CB Market for Cellular and Biological Simulation, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global CB Market for Disease Modelling and Drug Discovery, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global CB Market for Preclinical Drug Development, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 7 Global CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 8 Global CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 9 Global CB Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 10 North America CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 North America CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 12 North America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 13 North America CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 14 North America CB Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 15 Europe CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Europe CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 17 Europe CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 18 Europe CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 19 Europe CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 21 Asia Pacific CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 22 Asia Pacific CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 23 Asia Pacific CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 24 Asia Pacific CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 25 Latin America CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 26 Latin America CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 27 Latin America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 28 Latin America CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 29 Latin America CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 30 Middle East and Africa CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 31 Middle East and Africa CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 32 Middle East and Africa CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 33 Middle East and Africa CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 34 Middle East and Africa CB Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 35 Rhenovia Pharma SAS: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Chemical Computing Group Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Compugen, Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Accelrys: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 Insilico Biotechnology AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Nimbus Discovery LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 Entelos: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 Simulation Plus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 43 Genedata AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 44 Leadscope, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 45 Certara: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG 1. Computational Biology (CB) Market: Research Methodology
FIG 2. CB Market Segmentation
FIG 3. Global CB Market, by Application, 2017 (US$ Mn)
FIG 4. Global CB Market, by Component, 2017 (US$ Mn)
FIG 5. Global CB Market, by Service Type, 2017 (US$ Mn)
FIG 6. Global CB Market, by End User, 2017 (US$ Mn)
FIG 7. Global CB Market, by Geography, 2017 (US$ Mn)
FIG 8. Attractive Investment Proposition, by Geography, 2017
FIG 9. Competitive Analysis: Global CB Market, by Key Players, 2017
FIG 10. Global Computational Genomics Market, 2016-2026(US$ Mn)
FIG 11. Global Computational Proteomics Market, 2016-2026 (US$ Mn)
FIG 12. Global CB Market for Pharmacogenomics, 2016-2026 (US$ Mn)
FIG 13. Global CB Market for Transcriptomics/Metabolomics, 2016-2026 (US$ Mn)
FIG 14. Global CB Market for Target Identification, 2016-2026 (US$ Mn)
FIG 15. Global CB Market for Target Validation, 2016-2026 (US$ Mn)
FIG 16. Global CB Market for Lead Discovery, 2016-2026 (US$ Mn)
FIG 17. Global CB Market for Lead Optimization, 2016-2026 (US$ Mn)
FIG 18. Global CB Market for Pharmacokinetics, 2016-2026 (US$ Mn)
FIG 19. Global CB Market for Pharmacodynamics, 2016-2026 (US$ Mn)
FIG 20. Global CB Market for Clinical Trials, 2016-2026 (US$ Mn)
FIG 21. Global CB Market for Human Body Simulation, 2016-2026 (US$ Mn)
FIG 22. Global Computational Biology Hardware Market, 2016-2026 (US$ Mn)
FIG 23. Global Computational Biology Software & Services Market, 2016-2026 (US$ Mn)
FIG 24. Global Computational Biology Databases Market, 2016-2026 (US$ Mn)
FIG 25. Global In-house CB Market, 2016-2026 (US$ Mn)
FIG 26. Global Contract Services CB Market , 2016-2026 (US$ Mn)
FIG 27. Global CB Market for Industrial Applications, 2016-2026 (US$ Mn)
FIG 28. Global CB Market for Research and Academia, 2016-2026 (US$ Mn)
FIG 29. U.S. CB Market, 2016-2026 (US$ Mn)
FIG 30. Canada CB Market, 2016-2026 (US$ Mn)
FIG 31. U.K. CB Market, 2016-2026 (US$ Mn)
FIG 32. Germany CB Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Europe CB Market, 2016-2026 (US$ Mn)
FIG 34. China CB Market, 2016-2026 (US$ Mn)
FIG 35. Japan CB Market, 2016-2026 (US$ Mn)
FIG 36. Rest of Asia Pacific CB Market, 2016-2026 (US$ Mn)
FIG 37. Brazil CB Market, 2016-2026 (US$ Mn)
FIG 38. Mexico CB Market, 2016-2026 (US$ Mn)
FIG 39. Rest of Latin America CB Market, 2016-2026 (US$ Mn)
FIG 40. GCC CB Market, 2016-2026 (US$ Mn)
FIG 41. Rest of Middle East and Africa CB Market, 2016-2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)